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ABSTRACT
Primary thyroid lymphoma, although a rare malignancy, can arise in common chronic
inflammatory conditions such as Hashimoto’s thyroiditis. Incidental finding of a thyroid
nodule with chronic thyroid inflammation warrants further investigation. Early detection of
malignancy can play a vital role in improved outcomes. We report a case of a 60-year-old
male who presented to the clinic for a routine visit. An enlarged, firm, non-tender thyroid
gland was appreciated on exam with high thyroid stimulating hormone (TSH) level. Fine
needle aspiration of the mass revealed nonspecific atypical lymphocytes. The pathology and
immunohistochemical stains were consistent with histologic impression of extra nodal mar-
ginal B-cell lymphoma (mucosa-associated lymphoid tissue [MALT] lymphoma) and
Hashimoto’s thyroiditis. Patient was treated with thyroxine after complete surgical excision
of left thyroid lobe and remains in remission with close follow-up with his primary care
provider. Primary thyroid MALT lymphoma follows an indolent process and remains asympto-
matic in most patients. These are usually found to arise at sites of ongoing chronic inflam-
mation with underlying autoimmune or infectious etiologies. Treatment modalities include
surgical excision and/or radiation therapy for localized lesions, with both radiation and
chemotherapy indicated for disseminated disease.
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1. Background
Mucosa-associated lymphoid tissue (MALT) lymphoma
is defined as extra nodal lymphoma composed of hetero-
geneous small B cells arising from marginal zone of
MALT [1]. It most frequently occurs in the gastrointest-
inal tract mucosa (50%), head and neck (15%), lung
(14%), skin (11%), thyroid (4%), and breast (4%) [1–3].
Primary thyroid lymphoma (PTL) is a rare form of
malignancy, constituting about 2–8% of all thyroid
malignancies and 1–2% of all extra nodal lymphomas
[3,4]. Thyroid lymphomas are most commonly diffuse
large B-cell lymphomas (60–80%), and only about 30%
are extra nodal marginal zone lymphomas [3]. Primary
thyroid MALT lymphoma is rare, accounting 6–28% of
PTLs [5] and usually arises in the setting of chronic
lymphocytic thyroiditis, such as Hashimoto’s thyroiditis
[2]. Themean andmedian ages at diagnosis is between 65
and 75 years with 4:1 female predominance [5–7]. Co-
occurrence of papillary thyroid carcinoma has also been
reported [3,8]. Diagnosis requires a high degree of suspi-
cion and is often difficult due to coexistence of reactive as
well as neoplastic processes in the thyroid gland.
2. Case description
A 60-year-old male presented to our outpatient clinic
for a routine visit. He had no complaints except for
minimal hand dryness and denied fatigue, general-
ized weakness, heat or cold intolerance, constipation,
diarrhea, hair loss, or any recent weight changes. His
past medical history was pertinent for a basal cell
carcinoma of scalp treated with extensive excision
3 years prior.
On physical examination, an enlarged, firm, non-
tender thyroid gland was appreciated with about 3 cm
left thyroid lobe mass felt on palpation. Xerosis of
hands, arms, and legs were also noted with no prur-
itus or erythematous rash. No palpable lymphadeno-
pathies or hepatosplenomegaly was noted. He denied
any lump like sensation in his neck, neck pain, diffi-
culty in swallowing, hoarseness, or dry cough. Signs
of tracheal, esophageal, or neck vein compression
were not found. He was an active smoker (35 pack-
years) but did not have any history of radiation
exposure, family history of thyroid-related disorders,
or malignancy. His diet was normal with iodine-rich
meals.
Complete blood count and basic metabolic profile
were within normal limits. TSH was found to be
elevated at 10.14 uIU/mL. All other lab values were
within normal limit. Thyroid ultrasound was done
which revealed large 5.8 × 3.1 × 2.5 cm hypoechoic
mass occupying almost complete volume of the left
thyroid lobe, and persistent elevation of TSH was
found in repeat thyroid panel. Patient underwent
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fine needle aspiration (FNA) of the mass which
revealed ‘indeterminate follicular neoplasm’
(Bethesda category IV). The cytologic features were
suspicious for neoplastic process, and differential
diagnosis was broad including medullary thyroid car-
cinoma, neuroendocrine tumors, hematolymphoid
process, as well as metastatic malignancy.
With concern for malignancy, Positron Emission
Tomography – Computed Tomography (PET – CT)
scan was done. This revealed intensely hypermeta-
bolic left thyroid mass and mildly hypermetabolic
and prominent juxta thyroid lymph nodes in the left
neck. Diffuse uptake throughout the remainder of the
thyroid gland was present – a common finding asso-
ciated with Hashimoto’s thyroiditis. Considering
probable malignancy which was thus far undefined,
decision for thyroid lobectomy was made.
The pathology and immunohistochemical (IHC)
stains of the excised left thyroid lobe supported his-
tologic impression of extra nodal marginal B-cell
lymphoma (MALT lymphoma) with Hashimoto’s
thyroiditis. IHC indicated positivity for CD20,
CD79A, CD43, and CD45. IHC of Superior level 6
lymph node did not reveal any pathologic changes.
Bone marrow was performed subsequently which did
not show any evidence of infiltrating lymphoma.
Patient was determined to be at stage IAE (Ann
Arbor staging) considering his disease was limited to
the thyroid gland without marrow infiltration, evi-
dence of metastatic disease, or B symptoms. He was
started on thyroxine replacement and then referred to
Medical and Radiation Oncology, where further
radiation therapy was recommended. He remains in
a close follow-up with his primary care provider and
continues to be in remission. He deferred further
radiation therapy.
3. Discussion
Primary thyroid MALT lymphoma follows an indo-
lent course and presents without any overt symp-
toms. Although most lymphomas present with
typical ‘B’ symptoms such as fever, nocturnal sweat-
ing, and weight loss, this is usually not seen in this
disease process, which make the diagnosis even more
challenging [2,3]. Approximately 10% of patients may
have these symptoms and 10% may have features of
hypothyroidism, usually associated with Hashimoto’s
thyroiditis [6].
MALT lymphomas are initially recognized at
mucosal tissues, hence defined as tumors of
mucosa-associated origin. Since first described by
Isaacson and Wright [6], various extra nodal loca-
tions have been defined and studied. These were
usually found to arise at the sites where ongoing
chronic inflammation with underlying autoimmune
or infectious etiologies was observed [2]. For
example, MALT lymphoma of the stomach has been
associated with chronic infection with Helicobacter
pylori. A similar pathophysiology is seen with chronic
inflammation of thyroid gland in the setting of
ongoing Hashimoto’s thyroiditis, as observed in our
patient. Nevertheless, association of H. pylori and
thyroid MALT lymphoma has not been adequately
addressed in the literature [3]. Thyroid gland does
not contain any native lymphoid tissue; in fact, lym-
phoid tissues can only be seen in pathological condi-
tions, mostly involving autoimmune processes like
Hashimoto’s thyroiditis [2]. Histologically, lympho-
cytic infiltration of stroma with oxyphilic change of
follicular epithelium is seen in autoimmune thyroidi-
tis, as opposed to atypical lymphoid cells originating
within marginal zone of lymphoid follicles and
extending into interfollicular spaces and germinal
centers (follicular colonization) which is seen in
MALT lymphoma [2,3,6]. In our patient, FNA
showed neoplastic proliferation of mostly singly dis-
persed small- to medium-sized cells with lymphoid
cell proliferation, composed predominantly of small
mature lymphocytes. As can be seen in Figure 1,
histologic sections of thyroid parenchyma showing
architectural effacement by an atypical lymphoid
infiltrate with a focally nodular pattern. Also, demon-
strated in Figure 2 is a focus of intraluminal lym-
phoma cells, representing a so-called ‘MALT ball.’
IHC stain and phenotype of neoplastic cells of
MALT lymphoma are regarded to be virtually iden-
tical to that of non-neoplastic marginal zone B cells
which are positive for CD20, CD 22, and CD79A and
negative for CD5 and CD10.
Treatment of thyroid MALT lymphoma depends
upon its stage and subtype. Localized thyroid
MALT lymphoma can be treated with surgical
resection with 100% survival at 5 years [5,8–10].
Review of 103 cases done by Tsang et al. with
localized (stage IE/IIE) extra nodal MALT lym-
phoma had overall 5 years survival of 98% in 85
patients with extra nodal MALT lymphoma treated
with radiation therapy alone [11]. The optimal
treatment regimen and follow-up for these patients
remains controversial. Five-year disease-specific
survival has been found to be variable (35–79%)
in literature due to differences in population size,
study design, lymphoma classification, and treat-
ment modalities used [6]. The stage and histologic
grade do play a major role in determining prog-
nosis of the disease process. Diffuse large B-cell
lymphoma has a poorer prognosis compared to
localized primary MALToma. Stages I/II respond
well to localized treatment as compared to stages
III/IV which are more disseminated and need com-
bine modalities of chemo and radiation therapy
[6,10]. Patients who present with enlarging tumors
or symptoms of compression also have poorer
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prognosis [10]. Although this disease has excellent
survival rate after treatment, the optimal follow-up
remains controversial at present [5,10].
A usual practical approach is surgical excision for the
localized disease, followed by radiotherapy and che-
motherapy for disseminated disease [8]. However,
some recent studies support radiation therapy as a
primary modality of treatment in patients at Stages IE
and IIE and adjuvant therapy for those who are sus-
pected to have some residual disease even after thyroi-
dectomy procedure [3,12]. Unfortunately, due to rare
occurrence of PTL and lack of larger randomized con-
trolled studies, definitive guidelines for treatment and
follow-up on these patient groups are awaited.
Figure 1. Histologic sections of thyroid parenchyma on low power demonstrate architectural effacement by an atypical
lymphoid infiltrate with a focally nodular pattern.
Figure 2. Histologic sections demonstrate intraepithelial lymphocytosis with involvement of the thyroid epithelium by the
neoplastic lymphocytes. Shown is a focus of intraluminal lymphoma cells, representing a so-called ‘MALT ball’.
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4. Conclusion
Primary thyroid MALT lymphoma follows an indo-
lent process and remains asymptomatic in most
patients with occasional nonspecific symptoms. It
requires a high index of suspicion for diagnosis, and
should be considered in patients with chronic inflam-
matory conditions of thyroid in presence of thyroid
nodules. Treatment modalities include surgical exci-
sion and/or radiation therapy for localized lesions,
with both radiation and chemotherapy indicated for
disseminated disease.
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